Translate page

GoldmanPrize medal RGB reducFebruary 2019 - For ten years now, the International CML Foundation has been honouring people who have made outstanding contributions to our understanding of the biology of CML and to advance the management of CML.

There is now a long list of deserving awardees and we are very pleased to introduce you to the prize recipients in 2019:

  • Rowley Prize - Professor Michael Deininger (USA). This award acknowledges outstanding contributions to the understanding of the biology of CML and is awarded to Michael Deininger in recognition of his involvement in researching the biology of CML that has contributed to the establishment of TKI-based therapies and significantly changed the way CML is diagnosed, monitored and treated today.
  • Goldman Prize – Professor François-Xavier Mahon (France). This prize recognises outstanding contributions to the clinical management of CML and is awarded to François-Xavier Mahon for his pioneering work in leading the discussion on treatment-free remission and treatment discontinuation by providing solid scientific evidence through numerous pioneering studies.
  • iCMLf Prize – Dr Carolina Pavlovsky (Argentina). The iCMLf prize recognises outstanding contributions to improving the treatment of CML in the emerging economic regions. Carolina Pavlovsky receives the prize for her efforts to continually bringing in the ‘real-world’ perspective into the scientific discussion of CML management and for her commitment to finding workable solutions for those areas with limited access to resources. 

iCMLf Forum 2018 Hughes 1

January 2019 - On the iCMLf website you will now find webstreams of all the presentations held at the 2018 iCMLf Forum for Physicians from Emerging Regions.

  • Perspectives on treating CML in pregnant patients
    Professor Dragana Milojkovic (UK) and Dr Amma Benneh-Akwasi Kuma (Ghana)
  • Perspectives on treating CML in pediatric patients
    Professor Meinolf Suttorp (Germany)
  • Perspectives on adherence during TKI therapy
    Professor Saengsuree Jottar (Thailand)

CML Summary ASH 2018 Kopie

Expert interviews and scientific summary available

January 2019 - The iCMLf is pleased to present to you conference coverage from the CML education session at the American Society of Hematology Annual Meeting (ASH 2018) in San Diego. This includes expert video interviews with speakers on their perspectives on the session and a scientific summary report of this session and relevant abstracts.

These summaries have been created by Springer Healthcare IME, Springer’s independent medical education unit and are brought to you with support from Bristol Myers Squibb.

GoldmanPrize medal RGB reduc

November 2018 - The Foundation is celebrating its 10th anniversary next year. This also marks the tenth anniversary of our tradition to recognise and reward personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML around the world. It all started with the first iCMLf Rowley Prize awarded to Professor Brian Druker in 2009. This was followed by the introduction of the iCMLf Goldman Prize in 2014 and the iCMLf Prize in 2015.

We will continue this tradition next year. You are now welcome to nominate a colleague, or mentor for one of the 2019 prizes. Who would you like to see awarded the iCMLf prizes next year?

Timothy Hughes.pngCML Therapy: State of Science & CML Management, Practicalities

- New webcasts available

November 2018 - A new educational series has recently been added to the iCMLf Virtual Program. The new sessions feature key presentations from the COLT Meeting 2018, an annual CML Opinion Leader Training that takes place in Adelaide (Australia). The first sessions both chaired by Professor Timothy Hughes are now online:


Annual Report 20172018Proven programs and new visions -
iCMLf Annual Report 2017/2018

October 2018 - Over the past 10 years, we have worked hand in hand with our partners and experts to complete the mission of the iCMLf to improve the situation of patients with CML worldwide. In this Annual Report we would like to share with you what we have already achieved and our vision for the years to come. 

The Annual Report 2017/2018 features the iCMLf activities from Sept. 1st 2017 to August 31st 2018. 
Read more on the highlights in the iCMLf Annual Report 2017/2018 here.